Take a fresh look at your lifestyle.

COVID-19: FDA nyere ikike nkwado nke abụọ maka ndị otu adịghị ike.

0 678

Nlekọta nri na ọgwụ ọjọọ nke United States (FDA) na Tuesday, nyere ikike inye ọgwụ nkwado nke abụọ nke Pfizer-BioNTech ma ọ bụ ọgwụ Moderna COVID-19 maka ndị agadi na ụfọdụ ndị na-enweghị mgbochi.

Dị ka FDA si kwuo, “Enwere ike ịnye ọgwụ nkwado nke abụọ nke ọgwụ Pfizer-BioNTech COVID-19 ma ọ bụ ọgwụ Moderna COVID-19 nye ndị dị afọ 50 na karịa ma ọ dịkarịa ala ọnwa 4 ka ha nwetasịrị ọgwụ nkwalite mbụ nke ikike ọ bụla. ma ọ bụ ọgwụ COVID-19 kwadoro.”

Usoro nkwado nke abụọ nke ọgwụ mgbochi Pfizer-BioNTech COVID-19 ka a ga-enye ndị mmadụ gbara afọ 12 gbagowe nwere ụfọdụ ụdị immunocompromise opekata mpe ọnwa anọ ka ha nwetasịrị ọgwụ nkwalite mbụ.

A ga-enye ndị nọ n’afọ 18 gbagowe ọgwụ mgbochi nke abụọ nke ọgwụ mgbochi Moderna COVID-19 nwere otu ụdị immunocompromise.

FDA ekpebiela na uru ama ama yana uru nke ọgwụ mgbochi COVID-19 nke abụọ nwere nke ọ bụla n’ime ọgwụ mgbochi ndị a karịrị ihe egwu ama ama na enwere ike na ọnụọgụ ndị a.

Leave a Reply

Your email address will not be published. Required fields are marked *